Zaveri N - Search Results

1

NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.

Rawls SM, Schroeder JA, Ding Z, Rodriguez T, Zaveri N. Rawls SM, et al. Among authors: zaveri n. Neuropeptides. 2007 Aug;41(4):239-47. doi: 10.1016/j.npep.2007.03.001. Epub 2007 May 23. Neuropeptides. 2007. PMID: 17512052

2

Discovery and structure-activity relationships (SAR) of a novel class of 2-substituted N-piperidinyl indole-based nociceptin opioid receptor ligands.

Meyer ME, Doshi A, Polgar WE, Zaveri NT. Meyer ME, et al. Among authors: zaveri nt. Bioorg Med Chem. 2023 Sep 7;92:117421. doi: 10.1016/j.bmc.2023.117421. Epub 2023 Jul 21. Bioorg Med Chem. 2023. PMID: 37573822 Free PMC article.

3

Nonclassical 2,4-diamino-6-(aminomethyl)-5,6,7,8-tetrahydroquinazoline antifolates: synthesis and biological activities.

Gangjee A, Zaveri N, Kothare M, Queener SF. Gangjee A, et al. Among authors: zaveri n. J Med Chem. 1995 Sep 1;38(18):3660-8. doi: 10.1021/jm00018a027. J Med Chem. 1995. PMID: 7658454

4

The green tea component EGCG inhibits RNA polymerase III transcription.

Jacob J, Cabarcas S, Veras I, Zaveri N, Schramm L. Jacob J, et al. Among authors: zaveri n. Biochem Biophys Res Commun. 2007 Sep 7;360(4):778-83. doi: 10.1016/j.bbrc.2007.06.114. Epub 2007 Jul 2. Biochem Biophys Res Commun. 2007. PMID: 17624304 Free PMC article.

5

Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.

Rawls SM, Baron S, Ding Z, Roth C, Zaveri N, Raffa RB. Rawls SM, et al. Among authors: zaveri n. Neuropeptides. 2008 Jun;42(3):229-37. doi: 10.1016/j.npep.2008.03.005. Epub 2008 May 13. Neuropeptides. 2008. PMID: 18479746

6

NOP receptor pharmacological profile - A dynamic mass redistribution study.

Malfacini D, Simon K, Trapella C, Guerrini R, Zaveri NT, Kostenis E, Calo' G. Malfacini D, et al. PLoS One. 2018 Aug 30;13(8):e0203021. doi: 10.1371/journal.pone.0203021. eCollection 2018. PLoS One. 2018. PMID: 30161182 Free PMC article.

7

Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders.

Asth L, Tiago PRF, Costa LRF, Holanda VAD, Pacifico S, Zaveri NT, Calo' G, Ruzza C, Gavioli EC. Asth L, et al. Neuropeptides. 2020 Aug;82:102059. doi: 10.1016/j.npep.2020.102059. Epub 2020 Jun 15. Neuropeptides. 2020. PMID: 32600667

8

Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP.

Zaveri N, Jiang F, Olsen C, Polgar W, Toll L. Zaveri N, et al. AAPS J. 2005 Oct 5;7(2):E345-52. doi: 10.1208/aapsj070234. AAPS J. 2005. PMID: 16353914 Free PMC article. Review.

9

Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.

Farooqui M, Geng ZH, Stephenson EJ, Zaveri N, Yee D, Gupta K. Farooqui M, et al. Among authors: zaveri n. Mol Cancer Ther. 2006 Mar;5(3):611-20. doi: 10.1158/1535-7163.MCT-05-0016. Mol Cancer Ther. 2006. PMID: 16546975

10

NOP-Targeted Nonpeptide Ligands.

Zaveri NT, Meyer ME. Zaveri NT, et al. Handb Exp Pharmacol. 2019;254:37-67. doi: 10.1007/164_2019_213. Handb Exp Pharmacol. 2019. PMID: 31119463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters